Open Source Medicine

Open Source Medicine is a research organization that advances independent medicine through rigorous, peer-reviewed science—delivering evidence-based solutions from bench to bedside.

Open Source Medicine

End-to-End Translational Research Pipeline

Building the infrastructure to transform basic science discoveries into clinical solutions for healthcare transformation

1

Basic Science

Molecular mechanisms, biophysical modeling, computational analysis

  • Single-molecule biophysics
  • Structural biology
  • Computational modeling
  • Mechanistic pathway analysis
2

Translational Research

Evidence synthesis, therapeutic target identification, protocol development

  • Systematic reviews & meta-analyses
  • Therapeutic intervention design
  • Biomarker discovery
  • Safety signal analysis
3

Clinical Validation

Protocol testing, RCT design, real-world evidence generation

  • Phase II/III clinical trials
  • Multi-site network coordination
  • Patient outcome measurement
  • Regulatory pathway navigation
4

Healthcare Impact

Guideline development, policy influence, clinical implementation

  • Treatment guideline development
  • Medicare code advocacy
  • Physician education & CME
  • Health system partnerships
🔬

Biophysics Expertise

Our foundation in molecular biophysics—including optical tweezers, single-molecule techniques, and RNA structure analysis—enables us to understand disease mechanisms at the fundamental level. This scientific rigor translates to more robust therapeutic hypotheses.

🧬

Mechanistic Understanding

We don't just observe clinical outcomes—we understand why interventions work. Our research connects molecular pathways (mitochondrial dysfunction, spike protein pathology, metabolic dysregulation) to therapeutic strategies.

📊

Computational Modeling

Through collaborations with world-class computational biophysicists, we leverage in silico drug discovery, molecular dynamics simulations, and predictive modeling to accelerate therapeutic development.

🏥

Clinical Translation

Our multi-site clinical research network enables rapid translation from bench to bedside. We're positioned to validate therapeutic protocols through rigorous Phase II/III trials with real patient outcomes.

Global Research Network

Our distributed research infrastructure spans three continents, enabling specialized expertise and collaborative innovation

🏥

Honduras

Roatan & Tegucigalpa — Clinical Research Hub

  • Phase II/III clinical trials
  • PACVS diagnostic validation
  • Patient outcome measurement
  • Regulatory pathway development
🔬

Politecnico di Torino

Italy — Biophysics Center

  • Computational biophysics
  • Molecular dynamics simulations
  • In silico drug discovery
  • Research postdoc program
🧬

University of Alberta

Canada — Biophysics & Virology

  • Single-molecule biophysics
  • Post-viral syndrome mechanisms
  • Virology expertise
  • Core facility access

Why This Matters for Healthcare Transformation

Traditional pharmaceutical development is slow, expensive, and often disconnected from patient needs. Our end-to-end pipeline addresses this by:

Accelerating Discovery From mechanism to treatment in years, not decades
Reducing Costs Repurposed drugs and nutraceuticals offer affordable alternatives
Patient-Centered Focus Research driven by unmet clinical needs, not commercial interests
Open Science Principles Transparent methodology and accessible knowledge sharing

About Our Research Team

World-class scientists driving independent medical research across biophysics, integrative medicine, and translational science

MH

Matthew Halma

Director of Scientific Research

Matthew Halma leads Open Source Medicine's scientific research division. His work spans molecular biology, viral RNA structure, cancer metabolism, and post-viral pathology. With peer-reviewed publications in landmark journals including PNAS and Nature Communications, he has established Open Source Medicine as a credible force in integrative medicine research. His research on PACVS therapeutic protocols and pharmacovigilance methodology (DARE-SAFE) is shaping evidence-based approaches to post-vaccine injury.

Biophysics PACVS Cancer Metabolism Pharmacovigilance
JT

Jack Tuszynski, PhD

Senior Research Collaborator

University of Alberta Politecnico di Torino

Professor Tuszynski is a distinguished physicist and biophysicist with dual appointments at the University of Alberta (Canada) and Politecnico di Torino (Italy). A prolific researcher with expertise in computational biophysics, cancer research, and drug discovery, he has co-authored 8-10 papers with Open Source Medicine across cancer metabolism, aging, and integrative medicine. His collaboration brings world-class computational modeling and access to cutting-edge research facilities to Open Source Medicine's translational programs.

Computational Biophysics Cancer Research Drug Discovery Aging

Contract Research & Publishing Services

Accelerate your research agenda with Open Source Medicine's end-to-end scientific support—from concept to peer-reviewed publication

What We Offer

Open Source Medicine provides comprehensive contract research and publication services for pharmaceutical companies, biotech startups, nutraceutical brands, health systems, and foundations seeking rigorous, independent scientific validation of their products, protocols, or therapeutic approaches.

📝

Systematic Reviews & Meta-Analyses

Comprehensive literature synthesis following PRISMA guidelines to evaluate evidence for your therapeutic claims, ingredients, or interventions.

  • Protocol development & registration
  • Database searches (PubMed, Scopus, Cochrane)
  • Risk of bias assessment
  • Statistical meta-analysis
  • Peer-reviewed publication
Timeline: 3–6 months
📊

Narrative Reviews & Position Papers

Expert-authored review articles synthesizing the state of science for your therapeutic domain, product category, or clinical approach.

  • Topic scoping & outline development
  • Literature review & synthesis
  • Expert commentary & recommendations
  • Journal submission & peer review support
  • Open-access publication option
Timeline: 2–4 months
🔬

Original Research Studies

Design and execution of clinical studies, observational research, and mechanistic investigations to generate novel evidence.

  • Study design & protocol development
  • IRB/ethics approval support
  • Data collection & analysis
  • Biomarker & outcomes assessment
  • Manuscript preparation & publication
Timeline: 6–18 months
🎯

Computational & In Silico Analysis

Leverage our biophysics expertise for molecular modeling, drug-target interaction analysis, and predictive computational studies.

  • Molecular dynamics simulations
  • Structure-activity relationship modeling
  • Pathway analysis & network biology
  • Predictive toxicology screening
  • Publication-ready visualizations
Timeline: 2–6 months

Why Partner With Open Source Medicine?

Publication Track Record

40+ peer-reviewed papers in journals including PNAS, Nature Communications, Heliyon (Cell Press), and Frontiers. Your research benefits from our established credibility and journal relationships.

Q1 Journal Access

Our team consistently publishes in top-quartile (Q1) journals with impact factors 5–17. We navigate the peer review process efficiently, maximizing acceptance rates.

Biophysics & Mechanistic Depth

Unlike marketing-driven research firms, we bring fundamental scientific rigor. Our biophysics foundation enables us to explain why interventions work at the molecular level.

Independence & Credibility

As a 501(c)(3) nonprofit research organization, Open Source Medicine provides conflict-free scientific assessment. Our independence enhances the credibility of findings for regulators, clinicians, and consumers.

Integrative & Nutraceutical Expertise

Specialized expertise in herbal medicine, nutraceuticals, metabolic interventions, and integrative protocols—domains often underserved by traditional CROs.

Flexible Engagement Models

From single publication projects to multi-year research partnerships, we structure engagements to match your budget, timeline, and strategic objectives.

Ideal for Companies & Organizations Seeking:

Nutraceutical Brands Peer-reviewed evidence for ingredient efficacy claims
Biotech Startups Publication-ready research to support fundraising & regulatory submissions
Integrative Health Systems Evidence synthesis for protocol development & clinical guidelines
Foundations & Nonprofits Independent research on underserved conditions & therapies
Pharmaceutical Companies Repurposed drug research & real-world evidence generation
Medical Device Companies Clinical outcome studies & mechanism-of-action research

Engagement & Pricing

Project scoping is complimentary. We develop customized proposals based on your research objectives, timeline, and publication goals. Typical engagements range from $15,000 (narrative review) to $150,000+ (multi-site clinical study with publication).

Request a Research Consultation →

Start Your Research Project

Let's discuss how Open Source Medicine can support your evidence generation and publication goals.